Refine by
Testing In Animals Articles & Analysis: Older
38 news found
Developed by a team of esteemed researchers, the multi-type animal cognitive behavioral tests bring together cutting-edge technology, rigorous methodologies, and diverse animal models, allowing scientists to explore cognitive behavior in both traditional and non-traditional animal species. ...
Due to the complexity of these diseases, treatment remains a challenge. In the study of animal emotional behavior tests, researchers observed the behavior of animals to better understand how anxiety and depression affect their emotional responses. ...
This cutting-edge technology provides scientists and researchers with an innovative platform to study human organs in a way that was previously impossible, promising to accelerate drug discovery, reduce the need for animal testing and ultimately transform the future of medicine. Organs-on-chips, also known as microphysiological systems, are microfluidic cell ...
Viral vector manufacturing for preclinic development and clinical trials After developing a pre-clinical viral vector concept and confirmation that the product works in the animal model, viral vector manufacturingof clinical (GMP) material for extended toxicity studies and human clinical trials is required. ...
ByNuvonis
There is pharmacological evidence of activity of MET enabled enkephalin in morphine-tolerant animals. We believe the preliminary data from these early animal studies of NES100 support our belief that Envelta™ may have comparable preclinical activity to morphine in all animal pain models tested without the drug seeking, ...
The nasal delivery of the cell-based product has only been tested in animal models thus far. Changing the administration route of a cell-based therapy, as with any drug product, requires rigorous testing and is considered a different therapy requiring a set of pre-clinical and clinical testing according to applicable regulatory ...
The company applies a machine learning -driven approach to pre-flight medical advancements without extra trials or animal testing, allowing more patients to receive proper care and accelerating its partners' research findings. ...
The program reduces the time and cost of drug discovery and development and dramatically reduces the need for animal testing that, in the vast majority of cases, does not translate to ...
In silico modelling for CYP in preclinical species can also reduce animal testing in toxicology studies, making trials quicker, less expensive, and more ethical. ...
In addition, the company has also increased the porosity of the material. Benchtop and animal testing has shown that these changes have improved the material’s biocompatibility with the gingival tissues that surround tooth extraction sites. ...
Abingdon Health plc (AIM: ABDX), a leading international developer and manufacturer of high quality and effective rapid tests, announces the launch of its new B2C e-commerce website, abingdonsimplytest.com. ...
The program not only reduces the time and cost of drug discovery and development, it also greatly reduces the need for animal testing that, in the vast majority of cases, does not translate to ...
“MatTek has really pioneered the field of lab-grown tissues for preclinical testing, and we’ve had great success in developing multiple organ systems that have been shown to produce results much closer to live human responses than traditional animal testing,” said Kevin Causey, vice president of business development for MatTek. ...
This strategic expansion from MatTek aligns with the BICO Group’s strategy to increase accessibility to more sustainable solutions for drug testing and reducing the overall dependency on animal models. “Within the BICO Bioprinting Business Area we are seeing consistent growth in demand for tissue models and alternatives to animal ...
The funding follows IOP-Connect’s FDA Breakthrough Device Program (BDP) designation in 2020 and covers 2 activities: the integration of advanced technologies for the final product configuration -- including a rechargeable, thin-film microbattery; and a second round of bench testing and animal testing this year that will be managed by the ...
One of the major reasons for this low success rate stems from inadequate preclinical testing methods. Major challenges exist in compound screening by virtue of the limited techniques using cell lines, such as Caco-2 cells (Immortalized cancer cell lines), or animal studies. ...
The FDA recently provided helpful and positive feedback, including information on required animal testing and clinical trial design. Business Development In April 2021, the Company entered into an agreement with a Japanese therapeutic partner related to the Helix biotherapeutic delivery product candidates. ...
Even prior to the emergence of COVID-19, we have been pursuing a universal immune strategy against type A influenza (the most common and deadly form of seasonal and pandemic flu in both humans and animals), and we have discovered what we believe to be the Achilles’ heel of all type A influenza viruses. It potentially offers broad immunity against 100% of flu pandemics, 100% ...
When researchers develop a drug or study a disease in the lab, they use models and conduct in-vitro tests using, for example, petri dishes, or rely on animal testing. The test results are usually very limited, and the success rate for drug tests of the lung is less than 3%. ...
Stem Pharm’s neural model is expected to add tremendous value in neural toxicology screening and may help reduce the reliance on animal testing for the biopharmaceutical and industrial chemical ...